Raykov Rosty

Director | Chief Executive Officer | Chief Executive Officer

1 company

Average

Trades Analyzed

12M Win Rate

26.1%

Avg 3M Return

+0.2%

Avg 12M Return

-12.3%

Raykov Rosty is a Director at FENNEC PHARMACEUTICALS INC.. Recent SEC Form 4 filings include 1 buy and 15 sells.

Estimated insider holdings value: $666K based on current market prices.

Holdings by Company

FENCJan 2, 2026

Current Shares98.3K

Value$665.7K

Net Activity-323,867

Bought: 29.2KSold: 353.0K

Showing 9 filings (page 3)

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jul 2, 2024	FENC Fennec Pharmaceuticals Inc.	Chief Executive Officer	Sell	2,431	$6.13	$14,902.03	-1.3%	-17.1%	+41.6%
Jun 3, 2024	FENC Fennec Pharmaceuticals Inc.	Chief Executive Officer	Sell	2,431	$6.76	$16,433.56	-1.3%	-16.6%	+17.0%
May 1, 2024	FENC Fennec Pharmaceuticals Inc.	Chief Executive Officer	Sell	2,431	$9.11	$22,152.00	-1.3%	-30.4%	-32.8%
Apr 5, 2024	FENC Fennec Pharmaceuticals Inc.	Chief Executive Officer	Sell	88,583	$10.82	$958,668.92	-11.5%	-45.7%	-50.9%
Apr 3, 2024	FENC Fennec Pharmaceuticals Inc.	Chief Executive Officer	Sell	40,584	$10.78	$437,451.07	-6.6%	-44.0%	-48.1%
Apr 1, 2024	FENC Fennec Pharmaceuticals Inc.	Chief Executive Officer	Buy	29,167	$0.00	-	+10.1%	-42.2%	-49.0%
Dec 28, 2023	FENC Fennec Pharmaceuticals Inc.	Chief Executive Officer	Sale+OE	3,656	$11.55	$42,226.80	-1.3%	-4.5%	-46.4%
Nov 8, 2023	FENC Fennec Pharmaceuticals Inc.	Chief Executive Officer	Sell	25,044	$7.76	$194,267.31	-4.2%	+32.3%	-42.8%
Dec 30, 2022	FENC Fennec Pharmaceuticals Inc.	Chief Executive Officer	Sell	28,740	$9.61	$276,223.76	-3.1%	-10.9%	+16.9%